Quarterly report · Q1
2931.TEDINET S100QQ85
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.8bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥176m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥727m | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥111m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥81m | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥81m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥83m | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥167m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥40m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥168m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥44m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥63.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥60.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥40.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.4bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-1.46 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.36 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.36 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 35.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥425m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥52m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥52m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥227m |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥10.0bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥10.0bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥572m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥758m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥758m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | ¥249m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥370m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥21m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥21m |
| jpcrp040300-q1r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥178m |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥10.1bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥10.1bn |
| jpcrp040300-q1r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥129m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥676m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥676m |
| jpcrp040300-q1r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥48m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-03-31 | ¥10.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-03-31 | −¥356m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 1000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 0 | JPY |
| Other comprehensive income | Prior1YTDDuration | -13000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 41000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 30000000 | JPY |
| Comprehensive income | CurrentYTDDuration | -127000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 26000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -126000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 4000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -0 | JPY |
| Direct sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 8695000000 | JPY |
| Direct sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Direct sales | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Direct sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 8695000000 | JPY |
| Direct sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Direct sales | Prior1YTDDuration | 8695000000 | JPY |
| Distribution | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 860000000 | JPY |
| Distribution | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Distribution | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Distribution | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 860000000 | JPY |
| Distribution | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Distribution | Prior1YTDDuration | 860000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 365000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 365000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration | 365000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 202000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 21000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 676000000 | JPY |
| Others | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 901000000 | JPY |
| Others | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Others | Prior1YTDDuration | 901000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 10124000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 21000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 676000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10822000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from contracts with customers | Prior1YTDDuration | 10822000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | 10124000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | 21000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | 676000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 10822000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 10822000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E27054-000HealthCareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |